505 results on '"Gueyffier F"'
Search Results
2. MSR86 Use of Data Linkage for the Evaluation of Medical Devices: A Systematic Literature Review
3. Association between difference in blood pressure reduction and risk of cardiovascular events in a type 2 diabetes population: A meta-regression analysis
4. Preuves de bénéfice et décision thérapeutique : enquête auprès de médecins généralistes sur la prescription d’hydroxychloroquine pour traiter la Covid-19
5. Médicaments hypolipémiants
6. Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trials
7. PROJET REBUILD THE EVIDENCE
8. How individual participant data meta-analyses have influenced trial design, conduct, and analysis
9. Is HbA1c a valid surrogate for macrovascular and microvascular complications in type 2 diabetes?
10. Endodontic versus coronal treatment quality on the periapical status
11. Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross‐over controlled trial in a rare disease
12. Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: What is the level of evidence?
13. [OP.4A.03] PUBLIC HEALTH IMPACT OF CARDIOVASCULAR TREATMENTS IN PRIMARY PREVENTION: A SIMULATION STUDY ON A VIRTUAL REALISTIC POPULATION
14. [OP.3B.01] VALIDATION OF FRAMINGHAM AND SCORE IN 30560 PATIENTS WITH HYPERTENSION
15. [OP.1A.06] DOES DIABETES REALLY HARM WOMEN MORE THAN MEN? ANALYSES FROM 30560 INDIVIDUAL PATIENT DATA
16. Can we identify response markers to antihypertensive drugs? First results from the IDEAL Trial
17. Médicaments hypolipémiants
18. Les auteurs
19. KS02.4.A Olaparib in Recurrent IDH-mutant High-Grade Glioma (OLAGLI)
20. Efficacy of a home-based intervention programme on the physical activity level and functional ability of older people using domestic services: A randomised study
21. Are we using blood pressure-lowering drugs appropriately? Perhaps now is the time for a change
22. Twice- or Once-Daily Dosing of Direct Oral Anticoagulants, a systematic review and meta-analysis
23. Maintien de la rémission dans l’artérite à cellules géantes : comparaison indirecte des agents épargnant la corticothérapie par une revue systématique et une méta-analyse en réseau
24. Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France on volume and cost of drug deliveries, assessed with administrative databases
25. Existe-t-il une surmortalité chez les femmes dépistées par mammographie? Méta-analyse sur la mortalité non liée au cancer du sein
26. TOWARDS EQUITABLE STRATEGIES FOR HYPERTENSION MANAGEMENT IN CARDIOVASCULAR PREVENTION: O4
27. Syndrome de Klinefelter, rôle du chromosome Y dans l’espérance de vie humaine ?
28. Dynamical modeling of pro- and anti-inflammatory cytokines in the early stage of septic shock
29. Efficacité antalgique d’une prise orale de paracétamol chez l’adulte en soins primaires pour traiter la douleur aiguë
30. Modélisation et essais cliniques en pédiatrie
31. Modelling and Clinical Trials in Paediatrics
32. Lisibilité de l’information écrite destinée aux sujets se prêtant à une recherche biomédicale: Une nécessaire remise en question
33. Safety of computerized drug management: a case report
34. Méthodologie des essais cliniques de petits effectifs
35. Methodology for Small Clinical Trials
36. Which, and How Limited Number of Polymorphisms Should Be Selected per Disease, Risk Assessment, Health Profile or Biological System?
37. Hypertension Optimal Treatment (HOT) trial
38. EFFICACY OF TREATING HYPERTENSION IN WOMEN: ASSESSMENT OF DIFFERENCES IN AGE AND RACE FOR CARDIOVASCULAR OUTCOMES
39. Evaluation of the impact of terminating the reimbursement of a therapeutic class of drugs on the French health system: The example of symptomatic slow-acting drugs for osteoarthritis (SYSADOAs)
40. Effects of physical therapies aiming directly or indirectly at the recovery of balance after stroke. A meta-analysis
41. Effects of physical therapy on postural imbalance depending on time since stroke: A meta-analysis
42. L’interaction du sexe et du genre dans les essais contrôlés randomisés : une approche méta-épidémiologique
43. P034 Are patients with cystic fibrosis in clinical trials sensitive to the placebo effect? A metanalysis
44. Évaluation de l’impact du déremboursement d’une classe thérapeutique sur le système de santé français : l’exemple des anti-arthrosiques symptomatiques d’action lente (AASAL)
45. Prévalence des rechutes dans l’artérite à cellules géantes : une méta-analyse
46. Une ou deux fois par jour : quel est le meilleur schéma posologique pour les anticoagulants oraux directs ?
47. Therapie van hypertensie bij vrouwen van verschillende rassen
48. P2.29 An in Silico Model of the Role of Elastin on Geometry and Biomechanical Properties of Artery in Williams Beuren Syndrome
49. P5824HYCHeF: a risk score to predict congestive heart failure incidence in hypertension. (based on 18795 individual patient data)
50. Risk Reduction or Treat-To-Target Strategy? Economic Assessment of Statin use in Cardiovascular Prevention
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.